Genetic Analysis AS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Genetic Analysis AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10899
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. The company develops gene-based routine tests for the mapping and diagnosis of diseases related to dysbiosis and bacterial imbalances in the digestive system of irritable bowel syndrome and IBD patients. It services include gut microbiota, patient testing and clinical research services. Genetic Analysis provides gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients. The company’s technology utilizes common and variable DNA sequences within specified 16S rRNA gene of the bacteria to identify the different bacteria. Its GA-map ProbeTool software program uses search mechanisms to find combinations of DNA probes that can be used in the test. The company’s GA-map technology supports to generate profiles of a person’s microbiota and correlate such profiles to different health conditions. Genetic Analysis is headquartered in Oslo, Norway.

Genetic Analysis AS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genetic Analysis AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genetic Analysis AS, Medical Devices Deals, 2012 to YTD 2018 9
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Genetic Analysis Raises US$2 Million In Venture Financing 11
Partnerships 12
Genetic Analysis Enters into Agreement with Bio-Rad Labs 12
Licensing Agreements 13
Applied BioCode Enters Into Licensing Agreement With Genetic Analysis 13
Genetic Analysis AS – Key Competitors 14
Genetic Analysis AS – Key Employees 15
Genetic Analysis AS – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Genetic Analysis AS, Pharmaceuticals & Healthcare, Key Facts 2
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genetic Analysis AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genetic Analysis AS, Deals By Therapy Area, 2012 to YTD 2018 8
Genetic Analysis AS, Medical Devices Deals, 2012 to YTD 2018 9
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genetic Analysis Raises US$2 Million In Venture Financing 11
Genetic Analysis Enters into Agreement with Bio-Rad Labs 12
Applied BioCode Enters Into Licensing Agreement With Genetic Analysis 13
Genetic Analysis AS, Key Competitors 14
Genetic Analysis AS, Key Employees 15

List of Figures
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genetic Analysis AS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Genetic Analysis AS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Royal DSM NV (DSM):医療機器:M&Aディール及び事業提携情報
    Summary Royal DSM NV (DSM) is a science-based company with focus on materials, health and nutrition. It produces vitamins, carotenoids, nutritional lipids and other ingredients; specialty plastics; and fiber and resins solutions. DSM develops materials for medical devices and clean energy from crop …
  • Sihuan Pharmaceutical Holdings Group Ltd (460):製薬・医療:M&Aディール及び事業提携情報
    Summary Sihuan Pharmaceutical Holdings Group Ltd (Sihuan Pharmaceutical) is a pharmaceutical company that develops, manufactures and markets prescription drugs. The company offers products in the therapeutic areas of cardio-cerebral vascular system, central nervous system, metabolism, oncology and a …
  • Paul Hastings LLP:企業の戦略的SWOT分析
    Paul Hastings LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Nautilus Minerals Inc:企業の戦略・SWOT・財務情報
    Nautilus Minerals Inc - Strategy, SWOT and Corporate Finance Report Summary Nautilus Minerals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Entravision Communications Corp (EVC):企業の財務・戦略的SWOT分析
    Entravision Communications Corp (EVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • G M Breweries Ltd:企業の戦略・SWOT・財務分析
    G M Breweries Ltd - Strategy, SWOT and Corporate Finance Report Summary G M Breweries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • China UnionPay Co Ltd:企業の戦略・SWOT・財務分析
    China UnionPay Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China UnionPay Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Immunicum AB (IMMU)-製薬・医療分野:企業M&A・提携分析
    Summary Immunicum AB (Immunicum) is a biopharmaceutical company that develops immuno-oncology therapies for the treatment of solid tumors. The company’s products include COMBIG, CD70, SUBCUVAX and adenovirusvector. Its SUBCUVAX is in preclinical trials in combination with the adenovirus vector for t …
  • The Hackett Group, Inc.:企業の戦略・SWOT・財務分析
    The Hackett Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Hackett Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Academic Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Academic Medical Center (AMC), a subsidiary of University of Amsterdam is a medical center that offers research and educational services. The center offers services such as medical research, treatment of patients, and medical education services, among others. It provides its medical treatmen …
  • MADO Ice Cream & Foodstuffs Co., Ltd.:企業の戦略・SWOT・財務分析
    MADO Ice Cream & Foodstuffs Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary MADO Ice Cream & Foodstuffs Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Biocept Inc (BIOC)-製薬・医療分野:企業M&A・提携分析
    Summary Biocept Inc (Biocept) is a developer of diagnostic solutions. The company provides biopharmaceutical and clinical research, and molecular oncology laboratory services. It provides tests for various solid tumor cancers. Biocept offers related instrumentation, OncoCEE technology, and analytica …
  • National Oilwell Varco Inc (NOV):石油・ガス:M&Aディール及び事業提携情報
    Summary National Oilwell Varco Inc (NOV) is a provider of technology, equipment, and services to the oil and gas industry. The company’s portfolio of offerings includes rig systems, wellbore technologies, and completion and production solutions. Its product line comprises fiber glass systems, floati …
  • UCB SA (UCB):医療機器:M&Aディール及び事業提携情報
    Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines …
  • Kellstrom Defense Aerospace, Inc.:企業の戦略・SWOT・財務情報
    Kellstrom Defense Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kellstrom Defense Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • KARL STORZ SE & Co KG:企業の戦略的SWOT分析
    KARL STORZ SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Enel Russia (ENRU):電力:M&Aディール及び事業提携情報
    Summary Enel Russia, a subsidiary of Enel Investment Holding BV, is an energy utility. It produces electricity and thermal energy. The company generates electricity using coal, gas and fuel oil sources. Enel Russia owns and operates Konakovskaya GRES, Nevinnomysskaya GRES, Reftinskaya GRES and Sredn …
  • BerryPharma AG:企業の戦略・SWOT・財務情報
    BerryPharma AG - Strategy, SWOT and Corporate Finance Report Summary BerryPharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Breville Group Limited (BRG):企業の財務・戦略的SWOT分析
    Breville Group Limited (BRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • The British Land Company PLC:企業の戦略・SWOT・財務分析
    The British Land Company PLC - Strategy, SWOT and Corporate Finance Report Summary The British Land Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆